Infectious myositis

Best Practice and Research: Clinical Rheumatology

Volumn 20, Issue 6, 2006, Pages 1083-1097

  Crum Cianflone, Nancy F ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Clostridium spp; group A streptococcus; myositis; psoas abscess; pyomyositis; trichinosis

Indexed keywords

ALBENDAZOLE; ANTITOXIN; CLINDAMYCIN; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; MEBENDAZOLE; PENICILLIN G; PRAZIQUANTEL; SALICYLIC ACID DERIVATIVE; STEROID; VANCOMYCIN; ZIDOVUDINE;

BACTERIUM; CHAGAS DISEASE; CLOSTRIDIUM; CYSTICERCOSIS; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; EDEMA; FUNGUS; GAS GANGRENE; HUMAN; IMMUNE DEFICIENCY; INJURY; MUSCLE NECROSIS; MYALGIA; MYOSITIS; NONHUMAN; PARASITE; PATIENT CARE; PRIORITY JOURNAL; PYOMYOSITIS; REVIEW; SCHISTOSOMIASIS; STREPTOCOCCUS GROUP A; SURGICAL TECHNIQUE; TOXOCARIASIS; TRICHINOSIS; VIRUS; MICROBIOLOGY; PARASITOLOGY; PATHOPHYSIOLOGY; PSOAS ABSCESS; VIROLOGY;

GAS GANGRENE; HUMANS; MYOSITIS; PSOAS ABSCESS; PYOMYOSITIS;

EID: 33751180551     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2006.08.005     Document Type: Review

References (60)

1. Wortmann R.L. Inflammatory diseases of muscle and other myopathies. In: Harris E., Budd R., et al. (Eds). Kelley's Textbook of Rheumatology. 7th edn (2005), Saunders Elsevier, Philadelphia 1309-1335
2. Christopher-Stine L., and Plotz P.H. Myositis: an update on pathogenesis. Current Opinion in Rheumatology 16 (2004) 700-706
3. Wadia N.H., and Katrak S.M. Muscle infection: viral, parasitic, bacterial, and spirochetal. In: Schapira A.H.V., and Griggs R.C. (Eds). Muscle Diseases. 1st edn (1999), Butterworth Heinemann, Boston 339-362
4. Daley A.J., Atkinson M., and Nallusamy R. Group A streptococcal myositis. Journal of Paediatrics and Child Health 35 (1999) 588-590
5. Ichinose K., Migita K., Sekita T., et al. Parvovirus B19 infection and myofasciitis. Clinical Rheumatology 23 (2004) 184-185
6. Eliasson H., and Back E. Myositis and septicaemai caused by Francisella tularensis biovar holarctica. Scandinavian Journal of Infectious Diseases 5 (2003) 510-511
7. Wang J.Y., Lee L.N., Hsueh P.R., et al. Tuberculous myositis: a rare but existing clinical entity. Rheumatology 42 (2003) 836-840
8. Sharma M., Khatib R., Jones B.A., and Fakih M.G. Cryptococcus neoformans myositis without dissemination. Scandinavian Journal of Infectious Diseases 34 (2002) 858-859
9. Behar D.M., and Ben-Ami H. Myositis accompanying Rickettsia conorii infection. The Israel Medical Association Journal 3 (2001) 471-472
10. Field A.S., Marriott D.J., Milliken S.T., et al. Myositis associated with a newly described microsporidian, Trachipleistophora hominis, in a patient with AIDS. Journal of Clinical Microbiology 34 (1996) 2803-2811
11. Gave A.A., Torres R., and Kaplan L. Cryptococcal myositis and vasculitis: an unusual necrotizing soft tissue infection. Surgical Infections 5 (2004) 309-313
12. Agyeman P., Duppenthaler A., Heininger U., and Aebi C. Influenza-associated myositis in children. Infection 32 (2004) 199-203
13. Behan W.M., Behan P.O., Draper I.T., and Williams H. Does Toxoplasma cause polymyositis? Report of a case of polymyositis associated with toxoplasmosis and a critical review of the literature. Acta Neuropathologica 61 (1983) 246-252
14. Capo V., and Despommier D.D. Clinical aspects of infection with Trichinella spp. Clinical Microbiology Reviews 9 (1996) 47-54
15. Pasternack M.S., and Swartz M.N. Myositis. In: Mandel G.L., Bennett J.E., and Dolin R.D. (Eds). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th edn (2005), Elsevier/Churchill Livingstone, New York 1194-1204
16. Reimers C.D., de Koning J., Neubert U., et al. Borrelia burgdorferi myositis: report of eight patients. Journal of Neurology 240 (1993) 278-283
17. Smith R.D., Konoplev S., DeCourten-Myers G., and Brown T. West Nile virus encephalitis with myositis and orchitis. Human Pathology 35 (2004) 254-258
18. Brook I. Microbiology and management of myositis. International Orthopaedics 28 (2004) 257-260
19. Hu J.J., Kao C.L., Lee P.I., et al. Clinical features of influenza A and B in children and association with myositis. Journal of Microbiology, Immunology, and Infection 37 (2004) 95-98
20. Plonquet A., Bassez G., Authier F.J., et al. Toxoplasmic myositis as a presenting manifestation of idiopathic CD4 lymphocytopenia. Muscle Nerve 27 (2003) 761-765
21. Solomon T., Ooi M.H., Beasley D.W., and Mallewa M. West Nile encephalitis. British Medical Journal 326 (2003) 865-869
22. Horn C.V., and Master S. Pyomyositis tropicans in Uganda. East African Medical Journal 45 (1968) 463-471
23. Ansaloni L. Tropical pyomyositis. World Journal of Surgery 20 (1996) 613-617
24. Chiedozi L.C. Pyomyositis. Review of 205 cases in 112 patients. American Journal of Surgery 137 (1979) 255-259
25. O'Neill D.S., Baquis G., and Moral L. Infectious myositis: a tropical disease steals out of its zone. Postgraduate Medicine 100 (1996) 193-194 199-200
26. Crum N.F. Bacterial pyomyositis in the United States. American Journal of Medicine 117 (2004) 420-428
27. Fowler A., and Mackay A. Community-acquired methicillin-resistant Staphylococcus aureus pyomyositis in an intravenous drug user. Journal of Medical Microbiology 55 (2006) 123-125
28. Miyake H. Beitrage (Beitraege) zur Kenntnis der sogenannten Myositis Infectiosa. Mitteilungen aus den Grenzgebieten der Medizin und Chirurgie 13 (1904) 155-198
29. Smith I.M., and Vickers A.B. Natural history of 338 treated and untreated patients with staphylococcal septicaemia (1936-1955). Lancet 1 (1960) 1318-1322
30. Schwartzman W.A., Lambertus M.W., Kennedy C.A., and Goetz M.B. Staphylococcal pyomyositis in patients infected by the human immunodeficiency virus. American Journal of Medicine 90 (1991) 595-600
31. Widrow C.A., Kellie S.M., Saltzman B.R., and Mathur-Wagh U. Pyomyositis in patients with the human immunodeficiency virus: an unusual form of disseminated bacterial infection. American Journal of Medicine 91 (1991) 129-136
32. Chen W.-S., and Wan Y.-L. Iliacus pyomyositis mimicking septic arthritis of the hip joint. Archives of Orthopaedic and Trauma Surgery 115 (1996) 233-235
33. Chusid M.J., Hill W.C., Bevan J.A., and Sty J.R. Proteus pyomyositis of the piriformis muscle in a swimmer. Clinical Infectious Diseases 26 (1998) 194-195
34. Wysoki M.G., Angeid-Backman E., and Izes B.A. Iliopsoas myositis mimicking appendicitis: MRI diagnosis. Skeletal Radiology 26 (1997) 316-318
35. Walji S., Rubenstein J., Shannon P., and Carette S. Disseminated pyomyositis mimicking idiopathic inflammatory myopathy. The Journal of Rheumatology 32 (2005) 184-187
36. Ruiz M.E., Yohannes S., and Wladyka C.G. Pyomyositis caused by methicillin-resistant Staphylococcus aureus. New England Journal of Medicine 352 (2005) 1488-1489
37. Small L.N., and Ross J.J. Tropical and temperate pyomyositis. Infectious Disease Clinics of North America 19 (2005) 981-989
38. Van den Berge M., de Marie S., Kuipers T., et al. Psoas abscess: report of a series and review of the literature. The Netherlands Journal of Medicine 63 (2005) 413-416
39. Agrawal S.N., Dwivedi A.J., and Khan M. Primary psoas abscess. Digestive Diseases and Sciences 47 (2002) 2103-2105
40. Mallick I.H., Thoufeeq M.H., and Rajendran T.P. Iliopsoas abscesses. Postgraduate Medical Journal 80 (2004) 459-462
41. Gordin F., Stamler C., and Mills J. Pyogenic psoas abscesses: noninvasive diagnostic techniques and review of the literature. Reviews of Infectious Diseases 5 (1983) 1003-1011
42. El-Masry S. Spontaneous gas gangrene associated with occult carcinoma of the colon: a case report and review of the literature. International Surgery 90 (2005) 245-247
43. Boenicke L., Maier M., Merger M., et al. Retroperitoneal gas gangrene after colonoscopic polypectomy without bowel perforation in an otherwise healthy individual: report of a case. Langenbeck's Archives of Surgery 391 (2006) 157-160
44. Kennedy C.L., Krejany E.O., Young L.F., et al. The alpha-toxin of Clostridium septicum is essential for virulence. Molecular Microbiology 57 (2005) 1357-1366
45. Stevens D.L., Maier K.A., and Mitten J.E. Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrobial Agents and Chemotherapy 31 (1987) 213-218
46. Stevens D.L., Laine B.M., and Mitten J.E. Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene cause by Clostridium perfringens. Antimicrobial Agents and Chemotherapy 31 (1987) 312-316
47. Stevens D.L., Bryant A.E., Adams K., and Mader J.T. Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens. Clinical Infectious Diseases 17 (1993) 231-237
48. Wang C., Schwaitzberg S., Berliner E., et al. Hyperbaric oxygen for treating wounds: a systematic review of the literature. Archives of Surgery 138 (2003) 272-279
49. Hart G.B., Lamb R.C., and Strauss M.B. Gas gangrene. The Journal of Trauma 23 (1983) 991-1000
50. Subramanian K.N., and Lam K.S. Malignant necrotizing streptococcal myositis: a rare and fatal condition. The Journal of Bone and Joint Surgery. British Volume 85 (2003) 277-278
51. Stevens D.L., Tanner M.H., Winship J., et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. New England Journal of Medicine 321 (1989) 1-7
52. Adams E.M., Gudmundsson S., Yocum D.E., et al. Streptococcal myositis. Archives of Internal Medicine 145 (1985) 1020-1023
53. Stevens D.L., Gibbons A.E., Bergstrom R., and Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. The Journal of Infectious Diseases 158 (1988) 23-28
54. Darenberg J., Ihendyane N., Sjolin J., et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: A European randomized, double-blind, placebo-controlled trial. Clinical Infectious Diseases 37 (2003) 333-340
55. Jahnson L., Berggren L., Bjorsell-Ostling E., et al. Streptococcal myositis. Scandinavian Journal of Infectious Diseases 24 (1992) 661-665
56. Johnson D.A., Aulicino P.L., and Newby J.G. Bacillus cereus-induced myonecrosis. The Journal of Trauma 24 (1984) 267-270
57. Heckerling P.S., Stine T.M., Pottage J.C., et al. Aeromonas hydrophilia myonecrosis and gas gangrene in a nonimmunocompromised host. Archives of Internal Medicine 143 (1983) 2005-2007
58. Pozio E. New patterns of Trichinella infection. Veterinary Parasitology 98 (2001) 133-148
59. Pozio E., Sacchini D., Sacchi L., et al. Failure of mebendazole in the treatment of humans with Trichinella spiralis infection at the stage of encapsulating larvae. Clinical Infectious Diseases 32 (2001) 638-642
60. Wadia N.H. Dissemianted cystericercosis: pseudohypertrophic muscular type. In: Rose C.F. (Ed). Recent Advances in Tropical Neurology. 1st edn (1995), Elsevier, Amsterdam 119-130